U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07943728) titled 'Yangyin Qingfei Decoction for Radiation Pneumonitis Prevention' on Nov. 11.
Brief Summary: This prospective, randomized, controlled, open-label phase II clinical study will enroll patients with thoracic malignancies who are scheduled to receive thoracic radiotherapy and whose baseline chest CT/high-resolution CT (HRCT) shows no active pulmonary disease or prior radiation-induced lung injury that could interfere with the assessment of radiation pneumonitis (RP). Eligible patients will be randomized 1:1 to a treatment group or a control group. The control group will receive standard thoracic radiotherapy and routine supportive care; t...